This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Nature Reviews - Cardiology
FEBRUARY 27, 2024
Nature Reviews Cardiology, Published online: 28 February 2024; doi:10.1038/s41569-024-01004-2 Atrial fibrillation is the most common sustained arrhythmia and imposes a substantial burden on patients and health-care providers.
Science Daily - Heart Disease
AUGUST 12, 2024
Patients with a common heart arrhythmia called Atrial Fibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, according to a new article.
114 
DAIC
APRIL 9, 2024
An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
Science Daily - Heart Disease
APRIL 22, 2024
Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. Researchers have recently developed a deep-learning model capable of predicting the transition from a normal cardiac rhythm to atrial fibrillation.
105 
Med Page Today
DECEMBER 21, 2023
(MedPage Today) -- For patients undergoing catheter ablation for atrial fibrillation (Afib), there was no signal that a brief course of colchicine reduced atrial arrhythmia recurrence or improved clinical outcomes when taken for 10 days starting.
116 
DAIC
APRIL 18, 2024
Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. However, this reasoning disregards valuable data regarding early arrhythmia recurrences and their potential significance.
DAIC
MARCH 28, 2024
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Food & Drug Administration ( FDA ).
DAIC
DECEMBER 29, 2023
Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent.
Medical Xpress - Cardiology
SEPTEMBER 13, 2024
Atrial fibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heart failure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.
DAIC
MAY 18, 2024
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.
DAIC
JULY 24, 2024
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.
Medical Xpress - Cardiology
OCTOBER 5, 2024
A new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrial fibrillation, the most common type of abnormal heart rhythm.
Med Page Today
MAY 18, 2024
(MedPage Today) -- BOSTON -- For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after one procedure regardless of antiarrhythmic.
98 
Frontiers in Cardiovascular Medicine
JANUARY 16, 2024
Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Method Patient baseline characteristics and electrophysiological parameters were examined to identify the predictors of atrial fibrillation recurrence following catheter ablation. years following catheter ablation.
Dr. S. Venkatesan MD
APRIL 28, 2024
When atrial fibrillation (AF) begins, it can start with a single focus, degenerating to multiple wavelets, and it spreads throughout the entire surface area of both atria. A fibrillatory wave that occurs at a rate of more than 600 beats per minute can cause fatigue in the long run, leading to atrial dilation.
Circulation
NOVEMBER 29, 2023
Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureAtrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally.
Cardiomatics
APRIL 5, 2024
AFIB/AFL – atrial fibrillation or atrial flutter episodes. Other times, an irregular recording can signal a medical emergency, such as a myocardial infarction or a dangerous arrhythmia. 1] Arrhythmia Recognition: The Art of Interpretation, T.Garcia, D.Garcia.
92 
Open Heart
JANUARY 18, 2024
Introduction Three recent randomised controlled trials have demonstrated that pulmonary vein isolation as an initial rhythm control strategy with cryoablation reduces atrial arrhythmia recurrence in patients with symptomatic paroxysmal atrial fibrillation (PAF) compared with antiarrhythmic drug (AAD) therapy.
ECG Guru
DECEMBER 10, 2023
Atrial flutter and atrial fibrillation are 2 different cardiac arrhythmias, but occur frequently side by side in the same patient. Here is an example of how atrial flutter degenerataes into atrial fibrillation.
CTVS
AUGUST 22, 2023
It is estimated that more than 12 million people in the United States will have Atrial Fibrillation, or AFib in 2030. It is one of the most commonly diagnosed heart conditions and is characterized by an irregular heartbeat or rhythm, known as arrhythmia.
Medical Xpress - Cardiology
JANUARY 10, 2024
People taking medical cannabis for chronic pain have a slightly increased risk of arrhythmia, according to research published in the European Heart Journal today (Thursday). Arrhythmia is when the heart beats too slowly, too quickly or irregularly. It includes conditions like atrial fibrillation.
89 
Frontiers in Cardiovascular Medicine
JULY 31, 2024
Atrial fibrillation (AF) represents the most common cardiac arrhythmia with significant morbidity and mortality implications. This review aims to analyze the existing literature on the effects of dietary modifications on the incidence, progression, and outcomes of atrial fibrillation.
Dr. S. Venkatesan MD
NOVEMBER 22, 2024
Atrial fibrillation: Think locally act globally It is clear, except in specific situations like HT, LVH, HFpEF, and other left (or right )sided structural heart diseases, the bulk of the AF is part of systemic destabilization of neuro-metabolic homeostasis. Epicardial Fat and Atrial Fibrillation: A Review. 2017.11.001.
Circulation
AUGUST 4, 2024
Despite early evidence of an antiarrhythmic role of n-3 PUFA in the prevention of sudden cardiac death and postoperative and persistent atrial fibrillation (AF), subsequent well-designed randomized trials have largely not shown an antiarrhythmic benefit.
DAIC
FEBRUARY 2, 2024
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3 In: AF Symposium.;
105 
Frontiers in Cardiovascular Medicine
DECEMBER 18, 2023
Background Cryoballoon ablation (CBA) and laser balloon ablation (LBA) are two innovative ways for the treatment of atrial fibrillation (AF). This study aimed to evaluate the efficacy and safety of cryoballoon ablation and laser balloon ablation in patients with AF. LBA presented a lower acute PVI rate per patients (CBA 97.0%
Journal of the American Heart Association
FEBRUARY 13, 2024
BackgroundScreening for atrial fibrillation (AF) may reveal incidental arrhythmias of relevance. We furthermore report treatment decisions because of incidental arrhythmias. We found incidental arrhythmias in 94 patients (11.8%). Journal of the American Heart Association, Ahead of Print. of our cohort patients.
Frontiers in Cardiovascular Medicine
DECEMBER 14, 2023
Typical atrial flutter commonly occurs in patients with atrial fibrillation (AF). Limited information exists regarding the effects of concurrent atrial flutter on the long-term outcomes of rhythm control. Patients who were screened for typical atrial flutter were included in the analysis ( n  = 1,907).
Medical Xpress - Cardiology
SEPTEMBER 18, 2024
Arrhythmias, a group of disorders that disrupt the normal rhythm of the heart, can lead to serious health complications such as heart failure, stroke, and sudden death. The global prevalence of arrhythmias, particularly atrial fibrillation, is on the rise, contributing to substantial health and economic burdens.
Cardiovascular Diabetology
FEBRUARY 23, 2024
Objective We aimed to assess the effect of SGLT2i on arrhythmias by conducting a meta-analysis using data from randomized controlled trials(RCTs). Background Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have shown cardioprotective effects via multiple mechanisms that may also contribute to decrease arrhythmias risk.
The British Journal of Cardiology
NOVEMBER 10, 2023
Persistent cardiac arrhythmias are readily amenable to detection by performing a standard electrocardiogram (ECG), but detection of transient (paroxysmal) arrhythmias has long been a significant cause of frustration to both doctors and patients. This article aims to provide a helpful overview for patients and doctors advising them.
52 
HeartRhythm
APRIL 30, 2024
Atrial fibrillation is the most prevalent sustained cardiac arrhythmia and an important risk factor for ischemic stroke resulting in a fivefold increased stroke risk. The clinical utility of polygenic risk scores for ischemic stroke prediction among atrial fibrillation patients has not yet been established.
American College of Cardiology
DECEMBER 17, 2024
The ACC has issued new guidance on practical approaches for arrhythmia monitoring after stroke, offering clinicians tailored strategies to improve post-stroke care by identifying and managing atrial fibrillation (AFib) and other arrhythmias linked to recurrent stroke risk.
40 
Frontiers in Cardiovascular Medicine
JANUARY 15, 2024
Background Catheter ablation (CA) for symptomatic atrial fibrillation (AF) offers the best outcomes for patients. Results Our patient cohort was older, with higher BMI, greater CHA2DS2-VASc scores, and larger left atrial sizes compared to similar previously published cohorts, while gender balance and other characteristics were similar.
64 
HeartRhythm
APRIL 30, 2024
Animal studies suggest that catheter ablation-associated parasympathetic and sympathetic denervation could result in increased ventricular arrhythmias (VA). The impact of catheter ablation of atrial fibrillation on VA burden in humans has not been assessed.
Frontiers in Cardiovascular Medicine
DECEMBER 15, 2024
IntroductionLow atrial voltage and slow conduction velocity (CV) have been associated with atrial fibrillation (AF); however, their interaction and relative importance as early disease markers remain incompletely understood.
Frontiers in Cardiovascular Medicine
FEBRUARY 7, 2024
Background Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a high risk of stroke.
CardiacWire
SEPTEMBER 11, 2024
A JACC study suggests that atrial fibrillation is far more prevalent than many previously thought, estimating that nearly one in 20 American adults have been diagnosed with the disease. UCSF researchers analyzed medical records from 29M adults who received hospital-based care in California from 2005 to 2019 (51yr avg.
105 
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Background Pulmonary vein isolation with wide antral ablation leads to better clinical outcomes for the treatment of atrial fibrillation, but the isolation lesion is invisible in conventional cryoballoon ablation. The primary outcome was a clinical recurrence of documented atrial arrhythmias for >30 s during the 1-year follow-up.
Frontiers in Cardiovascular Medicine
OCTOBER 9, 2024
The primary outcome was ventricular arrhythmias, the secondary outcomes were bradycardia and atrial fibrillation (AF).ResultsOur Perioperative or postoperative use of DEX reduced the incidence of in-hospital ventricular arrhythmias [Odds Ratio (OR) 0.14, 95% Confidence Interval (CI) 0.03–0.66],
52 
HeartRhythm
DECEMBER 11, 2024
Asthma is a known risk factor for atrial fibrillation (AF), the most common sustained arrhythmia. While radiofrequency catheter ablation is effective in treating AF, the impact of asthma and its severity on ablation outcomes has not been previously explored.
Frontiers in Cardiovascular Medicine
MARCH 27, 2024
We reported the case of a 51-year-old woman who experienced multiple types of arrhythmias over three decades and was diagnosed with Danon disease late by genetic testing. Case summary A 51-year-old woman with a 36-year history of intermittent palpitations was admitted due to hemodynamically stable ventricular tachycardia (VT).
59 
HeartRhythm
JANUARY 25, 2024
Early recurrence of atrial arrhythmia (ERA) is commonly seen following catheter ablation of atrial fibrillation (AF), with reported incidences of up to 61% in the first three months.1
Frontiers in Cardiovascular Medicine
DECEMBER 15, 2023
Background Atrial fibrillation (AF) is a common cardiac arrhythmia that increases the risk of stroke and other cardiovascular complications. Oral anticoagulants (OACs) are effective in reducing this risk. To investigate the knowledge, attitude and practice (KAP) toward OACs among patients with AF.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content